Glaxosmithkline Pharmaceuticals Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '24
Dec '23
Sep '23
Jun '23
Mar '23
Total Qtr Revenue cr
959.63
833.37
985.20
798.10
815.11
Other Income Qtr Cr29.8328.1128.2136.4427.66
Operating Revenues Qtr929.80805.26956.99761.66787.45

*All values are in Cr.

Operating Expenses Qtr
672.54
587.20
667.50
617.78
617.71
Operating Profit Qtr
257.26
218.06
289.49
143.88
169.74
EBIDT Qtr Cr
289.49
82.86
317.70
197.62
207.80
Depreciation Qtr
18.10
17.11
18.11
16.36
17.18
Net Profit Qtr
194.48
45.72
217.51
132.25
133.43
Basic EPS Qtr
11.37
9.89
12.84
7.04
7.41
Open Demat Account
or Resume your Application
+91 -

personImage